期刊
JOURNAL OF MOLECULAR GRAPHICS & MODELLING
卷 27, 期 2, 页码 131-139出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jmgm.2008.03.007
关键词
Kappa opioid receptor; Pharmacophore; Peripherally restricted; Agonist; Analgesics; New chemical entities (NCEs); G-protein coupled receptor (GPCR)
类别
资金
- NIH [P20 RR 021929-01]
- Natural Products Neuroscience (CORE-NPN) fellowship
- NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021929] Funding Source: NIH RePORTER
In an effort to reduce or eliminate the centrally associated side effects produced by opioid analgesics there has been an interest in the preparation of peripherally acting opioid receptor agonists. These compounds would have very limited or no access to the central nervous system. As a first step towards developing peripheral kappa opioid receptor (KOP) agonists, we have developed a quantitatively predictive chemical function-based pharmacophore model of selective kappa opioid receptor agonists by using the HypoGen algorithm implemented in the Catalyst software. The input for HypoGen was a training set of 26 KOP agonists exhibiting K-i values ranging between 0.015 nM and 2300 nM. The best output hypothesis consists of four features: one hydrophobic (HYD), one ring aromatic (RA), one hydrogen bond acceptor (HBA), and one positive ionizable (PI) function. The predictive power of the model could be demonstrated by internal and external validation of the generated hypothesis. The resulting Catalyst pharmacophore can be used concurrently for rapid virtual screening of chemical databases to identify novel, selective KOP agonists that may be easily restricted to target tissues by synthetic modification. It is anticipated that such an approach will lead to the generation of novel selective KOP agonists that are clinically useful for the treatment of pain through peripheral mechanisms. (C) 2008 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据